Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2023-01-17 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于召开2023年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for convening the 2023 first extraordinary general meeting of shareholders of 盈康生命科技股份有限公司. It includes details about the meeting date, time, location, agenda items, voting procedures, and proxy authorization. It does not contain financial statements, audit results, or management discussion of financial performance. It is a formal announcement to shareholders about the meeting and how to participate, which fits the definition of a Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters and is primarily a meeting notice with voting instructions, not the report or results themselves.
2023-01-17 Chinese
关于全资子公司投资建设医疗器械数智生态园项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding an investment project by a wholly-owned subsidiary of the company. It details the investment overview, project specifics, approvals, risks, and impact on the company. There are no financial statements or detailed financial performance data included. The document is relatively short (3269 characters) and serves as a formal disclosure of a corporate action rather than a financial report or earnings release. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is a regulatory announcement about a capital investment project, which aligns best with Capital/Financing Update (CAP).
2023-01-17 Chinese
关于公司2023年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected related party transactions for the fiscal year 2023. It includes extensive information about the nature, amounts, pricing policies, and parties involved in these related party transactions. It also discusses the approval process, including board and shareholder meetings, and provides background on the related parties. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is not a call transcript, earnings release, or legal proceeding report. The content focuses on disclosure of related party transactions, which is typically part of regulatory compliance and shareholder information. Given the detailed nature and regulatory context, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. The document length (15,000 characters) and detailed content confirm it is not a brief announcement but a substantive regulatory filing.
2023-01-17 Chinese
第五届董事会第二十九次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the company's 29th interim meeting of the 5th Board of Directors. It details the meeting date, attendance, agenda items discussed, voting results, and references to related announcements on a public information platform. The content focuses on board decisions, including approval of related party transactions, investment projects, and calling a shareholders meeting. There is no financial data or report content, only meeting resolutions and procedural details. This fits the definition of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short and it is not a full report or financial statement, so it is not an Annual Report or Interim Report. Therefore, the classification is MANG with high confidence.
2023-01-17 Chinese
独立董事关于第五届董事会第二十九次（临时）会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on specific board meeting matters, focusing on related party transactions for the fiscal year 2023 and actual vs. expected transactions for 2022. It references compliance with company bylaws and stock exchange rules but does not contain financial statements or detailed financial data. The document is a formal opinion related to board/management matters rather than a full report or announcement of voting results. It is not a financial report, earnings release, or regulatory filing. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on governance and board opinions, supporting this classification.
2023-01-17 Chinese
关于全资子公司与专业投资机构共同投资暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about a transaction involving the company's wholly owned subsidiary and professional investment institutions jointly investing in another company. It includes information about the investment agreement, parties involved, shareholding structure changes, approval status, and the impact on the company. The document is not a financial report, earnings release, or management discussion but rather a disclosure of a capital investment transaction and related associated party (related party) transaction. It does not contain financial statements or quarterly/yearly financial results. The content fits best under Capital/Financing Update (CAP) as it details a capital increase and investment transaction involving the company and its related parties.
2022-12-22 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.